Pdt Partners, LLC Allogene Therapeutics, Inc. Transaction History

Pdt Partners, LLC

$1.01 Billion
Q1 2024

A detailed history of Pdt Partners, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 189,028 shares of ALLO stock, worth $440,435. This represents 0.08% of its overall portfolio holdings.

Number of Shares

189,028

Previous 15,944 1085.57%

Holding current value

$440,435

Previous $51,000 1554.9%

% of portfolio

0.08%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.92 - $5.63 $505,405 - $974,462	173,084 Added 1085.57%	189,028 $844,000
Q3 2023 Nov 14, 2023	BUY	$3.17 - $5.96 $50,542 - $95,026	15,944 New	15,944 $50,000
Q3 2022 Nov 14, 2022	SELL	$10.32 - $17.28 $877,385 - $1.47 Million	-85,018 Reduced 43.0%	112,701 $1.22 Million
Q2 2022 Aug 15, 2022	SELL	$6.78 - $12.28 $297,458 - $538,760	-43,873 Reduced 18.16%	197,719 $2.25 Million
Q1 2022 May 16, 2022	BUY	$7.65 - $15.29 $424,651 - $848,747	55,510 Added 29.83%	241,592 $2.2 Million

Q4 2021 Feb 14, 2022	BUY	$13.13 - $24.52 $1.67 Million - $3.12 Million	127,355 Added 216.86%	186,082 $2.78 Million
Q3 2021 Nov 15, 2021	SELL	$21.01 - $27.64 $2.21 Million - $2.9 Million	-105,101 Reduced 64.15%	58,727 $1.51 Million
Q2 2021 Aug 16, 2021	BUY	$23.49 - $35.8 $1.94 Million - $2.96 Million	82,563 Added 101.6%	163,828 $4.27 Million
Q1 2021 May 17, 2021	SELL	$25.79 - $39.02 $1.35 Million - $2.05 Million	-52,476 Reduced 39.24%	81,265 $2.87 Million
Q4 2020 Feb 16, 2021	BUY	$25.24 - $43.45 $928,781 - $1.6 Million	36,798 Added 37.96%	133,741 $3.38 Million
Q3 2020 Nov 16, 2020	BUY	$32.38 - $44.96 $3.14 Million - $4.36 Million	96,943 New	96,943 $3.66 Million
Q1 2020 May 15, 2020	SELL	$18.22 - $28.25 $284,960 - $441,830	-15,640 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$24.82 - $31.4 $388,184 - $491,096	15,640 New	15,640 $406,000

Others Institutions Holding ALLO

# of Institutions

164

Shares Held

106M

Call Options Held

97.5K

Put Options Held

45.6K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $335M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account